XML 50 R36.htm IDEA: XBRL DOCUMENT v3.20.4

REVENUE (Tables)

12 Months Ended

Oct. 31, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:

			Life Sciences and Applied Markets						Agilent CrossLab						Diagnostics and Genomics						Total
			(in millions)
Year Ended October 31, 2020:
Americas			$	784					$	667					$	517					$	1,968
Europe			540						532						371						1,443
Asia Pacific			1,068						701						159						1,928
Total			$	2,392					$	1,900					$	1,047					$	5,339
Year Ended October 31, 2019:
Americas			$	692					$	664					$	505					$	1,861
Europe			551						522						368						1,441
Asia Pacific			1,059						654						148						1,861
Total			$	2,302					$	1,840					$	1,021					$	5,163

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:

						Years Ended October 31,
						2020						2019
			(in millions)
Revenue by End Markets
Pharmaceutical and Biopharmaceutical						$	1,754					1,604
Chemical and Energy						1,154						1,199
Diagnostics and Clinical						787						785
Food						517						486
Academia and Government						526						474
Environmental and Forensics						601						615
Total						$	5,339					5,163
Revenue by Type
Instrumentation						$	2,249					2,150
Non-instrumentation and other						3,090						3,013
Total						$	5,339					5,163

Contract with Customer, Asset and Liability

The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the years ended October 31, 2019 and 2020:

						Contract Liabilities
						(in millions)
Ending balance as of October 31, 2018						$	367
Impact of adoption of new revenue recognition guidance						(11)
Net revenue deferred in the period						303
Revenue recognized that was included in the contract liability balance at the beginning of the period						(287)
Change in deferrals from customer cash advances, net of revenue recognized						5
Contract liabilities acquired in business combinations						9
Currency translation and other adjustments						—
Ending balance as of October 31, 2019						$	386
Net revenue deferred in the period						347
Revenue recognized that was included in the contract liability balance at the beginning of the period						(300)
Change in deferrals from customer cash advances, net of revenue recognized						9
Currency translation and other adjustments						4
Ending balance as of October 31,2020						$	446

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration